Cardlytics Sees Q3 Sales $34.000M-$39.000M vs $38.594M Est

Benzinga Newsdesk www.benzinga.com Positive 76.3%

Neg 0% Neu 0% Pos 76.3%

Cardlytics (NASDAQ:CDLX) sees Q3 sales of $34.000 million-$39.000 million vs $38.594 million analyst estimate.

Comments

No comments yet. Be the first!